Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Q1 2024 Earnings Call Transcript
Operator: Good morning, everyone. Thank you for joining the Zevra Therapeutics' First Quarter 2024 Corporate Update and Financial Results Call.
Zevra Therapeutics Inc. (ZVRA)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 2,453,405 | $14,229,749 | 0.81% | |
| 2. | Woodline Partners Michael Rockefeller And Karl Kroeker | 1,009,617 | $5,855,779 | 0.05% | |
| 3. | 683 Capital Partners Ari Zweiman | 800,000 | $4,640,000 | +48% | 0.33% |
| 4. | Altium Capital Jacob Gottlieb | 341,461 | $1,980,474 | 0.78% | |
| 5. | Point72 Asset Management Steve Cohen | 90,802 | $526,652 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.13 | 500 | Officer | 3,500 | 2023-09-05 | Filing | |
| $4.96 | 1,000 | Officer | 15,309 | 2023-09-06 | Filing | |
| $5.13 | 10,000 | Director | 20,000 | 2023-09-05 | Filing | |
| $4.88 | 10,000 | Director | 10,000 | 2023-09-06 | Filing | |
| $5.42 | 1,000 | Officer | 3,000 | 2023-05-19 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,410,289 | $15,787,393 | 0% | |
| 2. | 1,645,140 | $10,775,667 | 0% | |
| 3. | 729,179 | $4,776,597 | 0% | |
| 4. | 636,060 | $4,166,193 | 0% | |
| 5. | 387,427 | $2,537,647 | 1.14% |
News See All
Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Q4 2023 Earnings Call Transcript
Zevra Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.4 EPS, expectations were $-0.2.
Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Q3 2023 Earnings Call Transcript
Operator: Good morning, everyone. Thank you for joining the Zevra Therapeutics Third Quarter 2023 Corporate Updates and Financial Results Call.
Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Q2 2023 Earnings Call Transcript
Operator: Good morning, and welcome to the Zevra Therapeutics Second Quarter 2023 Corporate and Financial Results Conference Call.
Billionaire Hedge Funds
